GAD1 and diabetes mellitus: 25 patients (14 ‘diabetes only’, 11 neurological diseases) were excluded from quantitative analysis as their GAD-Ab values were recorded as > 2000 IU/mL (i.e., the top standard of the ELISA assay) and not titrated.